Synthetic Biologics, Inc. (SYN)

Operating Cash Flow Growth

25.20%

TTM · Period ending:

SYN logo

SYN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported25.20%
SYN TTM Cash from Operations YoY % (-84.21% → 25.20%)
High-resolution chart · PNG

SYN operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Synthetic Biologics, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
25.2011%
17.1195%
1.5823%
-37.4585%
-48.0372%
-46.0832%
-37.2817%
-5.9336%
11.3045%
18.6552%
27.8801%
12.2901%
6.7635%
3.1565%
5.284%
19.7118%
24.3457%
25.1818%
23.926%
14.4773%
32.7694%
32.9788%
28.192%
27.5868%
6.4275%
25.456%
27.7988%
28.2566%
12.8811%
-71.2651%
-116.4499%
-141.8683%
-133.4976%
-96.8183%
-89.64%
-108.3042%
-43.0732%
-17.6551%
-3.9725%
13.4253%
-99.8016%
-117.7188%
-127.2013%
-210.1217%
-76.2657%
-58.0318%
-611.1397%
-152.216%
-124.9864%
-164.8429%
82.1735%
60.9473%
57.0303%
67.2755%
11.7942%
39.838%
54.8516%
56.1202%
45.3908%
26.5661%
-27.2563%
-94.2555%
-80.3915%
-179.2631%
-77.3215%
-72.8285%
-64.6369%
-40.4369%
-366.7109%
-114.7062%
-24.1865%
89.1528%
87.3559%
79.4373%
50.6826%
27.7967%
-24.2923%
-89.0262%
-101.6165%
-42.8724%
63.2003%
71.1588%
73.1005%
65.0245%
-364.3917%
-315.1457%
12.6315%
13.6715%
79.6791%
76.2431%
-286%
-179.1045%
-156.1644%
-138.1579%
23.0769%
-11.6667%
-2.8169%
-6.4426%
19.0535%
20%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.